FRES
Price
$0.85
Change
-$0.27 (-24.11%)
Updated
Dec 23 closing price
Capitalization
2.08M
KZIA
Price
$1.40
Change
+$0.03 (+2.19%)
Updated
Jan 23, 04:01 PM (EDT)
Capitalization
6.9M
Ad is loading...

FRES vs KZIA

Header iconFRES vs KZIA Comparison
Open Charts FRES vs KZIABanner chart's image
Fresh2 Group
Price$0.85
Change-$0.27 (-24.11%)
Volume$285.05K
Capitalization2.08M
Kazia Therapeutics
Price$1.40
Change+$0.03 (+2.19%)
Volume$150
Capitalization6.9M
FRES vs KZIA Comparison Chart
Loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FRES vs. KZIA commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRES is a Hold and KZIA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 23, 2025
Stock price -- (FRES: $0.85 vs. KZIA: $1.37)
Brand notoriety: FRES and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FRES: 204% vs. KZIA: 80%
Market capitalization -- FRES: $2.08M vs. KZIA: $6.9M
FRES [@Biotechnology] is valued at $2.08M. KZIA’s [@Biotechnology] market capitalization is $6.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FRES’s FA Score shows that 1 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • FRES’s FA Score: 1 green, 4 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, FRES is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FRES’s TA Score shows that 1 TA indicator(s) are bullish while KZIA’s TA Score has 3 bullish TA indicator(s).

  • FRES’s TA Score: 1 bullish, 1 bearish.
  • KZIA’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, KZIA is a better buy in the short-term than FRES.

Price Growth

FRES (@Biotechnology) experienced а 0.00% price change this week, while KZIA (@Biotechnology) price change was -11.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.05%. For the same industry, the average monthly price growth was +3.28%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

FRES is expected to report earnings on May 16, 2023.

Industries' Descriptions

@Biotechnology (+4.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KZIA($6.9M) has a higher market cap than FRES($2.09M). FRES YTD gains are higher at: 0.000 vs. KZIA (-22.599). KZIA has higher annual earnings (EBITDA): -17.52M vs. FRES (-131.06M). FRES has higher revenues than KZIA: FRES (17M) vs KZIA (0).
FRESKZIAFRES / KZIA
Capitalization2.09M6.9M30%
EBITDA-131.06M-17.52M748%
Gain YTD0.000-22.599-
P/E RatioN/AN/A-
Revenue17M0-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FRESKZIA
RSI
ODDS (%)
N/A
Bullish Trend 16 days ago
90%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bullish Trend 16 days ago
75%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
85%
Bearish Trend 16 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 25 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 16 days ago
86%
Aroon
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 16 days ago
83%
View a ticker or compare two or three
Ad is loading...
FRES
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTRN4.480.41
+10.07%
Lantern Pharma
ELP6.350.21
+3.42%
Companhia Paranaense de Energia - COPEL
CPRT57.660.22
+0.38%
Copart
LILA6.88-0.06
-0.86%
Liberty Latin America Ltd
CERS1.81-0.04
-2.16%
Cerus Corp

FRES and

Correlation & Price change

A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FRES
1D Price
Change %
FRES100%
N/A
HOOK - FRES
75%
Closely correlated
-2.45%
KZIA - FRES
57%
Loosely correlated
-4.86%
NKTR - FRES
34%
Loosely correlated
+1.55%
QURE - FRES
32%
Poorly correlated
+2.55%
KPRX - FRES
31%
Poorly correlated
-3.25%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with HOOK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-4.86%
HOOK - KZIA
66%
Loosely correlated
-2.45%
FRES - KZIA
56%
Loosely correlated
N/A
CLNN - KZIA
33%
Poorly correlated
-2.50%
RVMD - KZIA
29%
Poorly correlated
+1.89%
PRTC - KZIA
28%
Poorly correlated
-0.68%
More